Education
About Us
Working with TipRanks
Follow Us
Schrodinger, Inc. (SDGR)
:SDGR
SDGR Stock Chart & Stats
$22.17
-$1.19(-5.63%)
At close: 4:00 PM EST
$22.17
-$1.19(-5.63%)
Day’s Range― - ―
52-Week Range$16.60 - $28.47
Previous CloseN/A
Volume166.74K
Average Volume (3M)1.23M
Market Cap
$1.66B
Enterprise Value$1.13B
Total Cash (Recent Filing)$462.26M
Total Debt (Recent Filing)$114.31M
Price to Earnings (P/E)―
Beta1.81
Next Earnings
Nov 05, 2025EPS Estimate
-0.72Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.59
Shares Outstanding64,441,780
10 Day Avg. Volume1,438,456
30 Day Avg. Volume1,226,230
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)3.33
Price to Sales (P/S)6.75
P/FCF Ratio-8.51
Enterprise Value/Market Cap0.68
Enterprise Value/Revenue4.75
Enterprise Value/Gross Profit8.12
Enterprise Value/Ebitda-6.40
Forecast
1Y Price Target
$25.25Price Target Upside13.89% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
Bulls Say, Bears Say
Bulls Say
Cost ManagementManagement confirmed operating expenses should land below prior rates, reflecting success in cost-cutting initiatives.
Product InnovationSchrodinger's predictive toxicology software is in beta testing and could be launched soon, offering a new revenue stream.
Strategic CollaborationsPotential positive data from Ph1 SGR-1505 and SGR-3515 could validate SDGR's platform and provide proof-of-concept for collaborations.
Bears Say
Macroeconomic PressuresIndustry macroeconomic headwinds have persisted, placing pressure on topline growth for the software segment.
Market SentimentDowngrading Schrödinger to Neutral/High Risk from Buy/High Risk with a new PT of $20, down from $35, reflects reduced market confidence.
Program TerminationDevelopment for SGR-2921 will be discontinued after two clinical trial patient deaths, impacting confidence in the platform.
Schrodinger News
SDGR FAQ
What was Schrodinger, Inc.’s price range in the past 12 months?
Schrodinger, Inc. lowest stock price was $16.60 and its highest was $28.47 in the past 12 months.
What is Schrodinger, Inc.’s market cap?
Schrodinger, Inc.’s market cap is $1.66B.
When is Schrodinger, Inc.’s upcoming earnings report date?
Schrodinger, Inc.’s upcoming earnings report date is Nov 05, 2025 which is in 7 days.
How were Schrodinger, Inc.’s earnings last quarter?
Schrodinger, Inc. released its earnings results on Aug 06, 2025. The company reported -$0.59 earnings per share for the quarter, beating the consensus estimate of -$0.768 by $0.178.
Is Schrodinger, Inc. overvalued?
According to Wall Street analysts Schrodinger, Inc.’s price is currently Undervalued.
Does Schrodinger, Inc. pay dividends?
Schrodinger, Inc. does not currently pay dividends.
What is Schrodinger, Inc.’s EPS estimate?
Schrodinger, Inc.’s EPS estimate is -0.72.
How many shares outstanding does Schrodinger, Inc. have?
Schrodinger, Inc. has 64,441,780 shares outstanding.
What happened to Schrodinger, Inc.’s price movement after its last earnings report?
Schrodinger, Inc. reported an EPS of -$0.59 in its last earnings report, beating expectations of -$0.768. Following the earnings report the stock price went up 0.103%.
Which hedge fund is a major shareholder of Schrodinger, Inc.?
Currently, no hedge funds are holding shares in SDGR
Schrodinger Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$25.25 (13.89% Upside)
$25.25 (13.89% Upside)
Blogger Sentiment
Bullish
SDGR Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 834.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.7%
Last 30 Days ▲ 3.4%
Last 30 Days ▲ 3.4%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
25.39%
12-Months-Change
Fundamentals
Return on Equity
-44.40%
Trailing 12-Months
Asset Growth
-0.02%
Trailing 12-Months
Company Description
Schrodinger, Inc.
Schrodinger, Inc. is a technology company that focuses on advancing drug discovery and materials science by leveraging computational modeling and simulation. The company operates primarily in the life sciences and materials science sectors, providing software solutions and services that enhance the efficiency and effectiveness of research and development processes. Schrodinger's core products include its computational platform, which integrates physics-based simulations with machine learning to assist researchers in designing new molecules for pharmaceuticals and materials.
SDGR Company Deck
SDGR Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant revenue growth and strong pipeline progress, alongside effective expense management and a robust cash position. However, these positives were offset by challenges in maintaining software gross margins, difficulties in the biotech segment, and continued net losses. The sentiment is balanced with notable progress and ongoing challenges.View all SDGR earnings summariesSDGR Stock 12 Month Forecast
Average Price Target
$25.25
▲(13.89% Upside)
Technical Analysis
Ownership Overview
2.40% Insiders
20.89% Mutual Funds
<0.01% Other Institutional Investors
52.43% Public Companies and
Individual Investors